Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant
Author:
Affiliation:
1. Division of Gastroenterology; Department of Medicine; University of Massachusetts Medical Center; Worcester MA USA
2. Division of Transplant Surgery; Department of Surgery; University of Massachusetts Medical Center; Worcester MA USA
Publisher
Wiley
Subject
Transplantation
Reference28 articles.
1. Hepatitis C virus treatment pre- and post-liver transplantation;Roche;Liver Int,2012
2. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002
3. Long-term outcome of hepatitis C infection after liver transplantation;Gane;N Engl J Med,1996
4. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group;Feray;Gastroenterology,1999
5. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience;Ghobrial;Ann Surg,1999
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review;Hepatology International;2022-09-09
2. Efficacy and safety of sofosbuvir-containing regimens in patients with chronic hepatitis C virus infection after liver transplantation: a meta-analysis;Annals of Translational Medicine;2020-05
3. Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis;Transplant Infectious Disease;2019-01-21
4. Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C;Transplantation Proceedings;2019-01
5. Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience;Journal of Medical Virology;2018-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3